UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000027387 |
|---|---|
| Receipt number | R000031386 |
| Scientific Title | Effectiveness and Safety of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligo-synovitis Resistant to Prior TNF-alpha Inhibitors |
| Date of disclosure of the study information | 2017/05/25 |
| Last modified on | 2021/05/21 10:48:31 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/05/18 17:43:40 | ||
| 2 | Update | 2017/05/18 17:50:02 | Email1 |
|
| 3 | Update | 2017/11/17 13:58:02 | Other related information |
|
| 4 | Update | 2019/05/22 17:44:45 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization2 Address2 Tel2 Email2 Organization3 Address3 Tel3 Email3 Organization Organization Address Address Tel |
|
| 5 | Update | 2019/05/22 17:46:04 | Recruitment status Date of IRB |
|
| 6 | Update | 2019/05/22 17:47:17 | Number of participants that the trial has enrolled |
|
| 7 | Update | 2019/11/19 12:36:35 | Date of closure to data entry |
|
| 8 | Update | 2021/05/21 10:48:31 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
